Human platelet alloantigens HPA-1, HPA-2, and HPA-3 polymorphisms associated with extent of severe coronary artery disease

Journal of Thrombosis and Thrombolysis

Volumn 29, Issue 4, 2010, Pages 409-415

  Abboud, Nesrine ^a   Ghazouani, Lakdhar ^a   Ben Hadj khalifa, Sonia ^a   Anabi, Fatma ^b   Added, Faouzi ^b   Khalfallah, Ali ^b   Nsiri, Brahim ^c   Almawi, Wassim Y ^d   Mahjoub, Touhami ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c MILITARY HOSPITAL OF TUNIS   (Tunisia)

^d Military Hospital ^*

Author keywords

Coronary artery disease; Gene polymorphism; Human platelet alloantigens; PCR

Indexed keywords

HUMAN PLATELET ALLOANTIGEN 1; HUMAN PLATELET ALLOANTIGEN 2; HUMAN PLATELET ALLOANTIGEN 3; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY RISK; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; AGED; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM;

AGED; ANTIGENS, HUMAN PLATELET; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77955483305     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0368-5     Document Type: Article

References (42)

1. Davies MJ (1995) Acute coronary thrombosis-the role of plaque disruption and its initiation and prevention. Eur Heart J 16:3-7
2. Fischer M, Broeckel U, Holmer S, Baessler A, Hengstenberg C, Mayer B, Erdmann J, Klein G, Riegger G, Jacob HJ, Schunkert H (2005) Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 111:855-862
3. Wang Q (2005) Molecular genetics of coronary artery disease. Curr Opin Cardiol 20:182-188 (Pubitemid 40704874)
4. Hackam DG, Anand SS (2003) Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA 290:932-940
5. Topol EJ (2005) The genomic basis of myocardial infarction. J Am Coll Cardiol 46:1456-1465
6. Lentz SR (2005) Another lesson from the factor V Leiden mouse: thrombin generation drives arterial disease. Circulation 111:1733-1734
7. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J (2006) Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66, 155 cases and 91, 307 controls. Lancet 367:651-658
8. Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z, Chesebro JH (2000) Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 134:224-238
9. Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8:1227-1234
10. Santoso S (2003) Human platelet alloantigens. Transfus Apher Sci 28:227-236
11. Calvete JJ (1999) Platelet integrin GPIIb/IIIa: structure-function correlations. An update and lessons from other integrins. Proc Soc Exp Biol Med 222:29-38
12. Deckmyn H, Ulrichts H, Van De Walle G, Vanhoorelbeke K (2004) Platelet antigens and their function. Vox Sang 87 (Suppl 2):105-111
13. Bray PF (2000) Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol 7:284-289
14. Moshfegh K, Wuillemin WA, Redondo M, Lämmle B, Beer JH, Liechti-Gallati S, Meyer BJ (1999) Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 353:351-354
15. Ulrichts H, Vanhoorelbeke K, Cauwenberghs S, Vauterin S, Kroll H, Santoso S, Deckmyn H (2003) von Willebrand Factor but not α-thrombin binding to platelet glycoprotein Ibα is influenced by the HPA-2 polymorphism. Arterioscler Thromb Vasc Biol 23:1302-1307
16. Halle L, Bigot A, Mulen-Imandy G, M'Bayo K, Jaeger G, Anani L, Martageix C, Bianchi F, Julien E, Kaplan C (2005) HPA polymorphism in sub-Saharan African populations: Beninese, Cameroonians, Congolese, and Pygmies. Tissue Antigens 65:295-298
17. Seo DH, Park SS, Kim DW, Furihata K, Ueno I, Han KS (1998) Gene frequencies of eight human platelet-specific antigens in Koreans. Transfus Med 8:129-132
18. Yan L, Zhu F, He J, Sandler SG (2006) Human platelet alloantigen systems in three Chinese ethnic populations. Immunohematology 22:6-10
19. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ (1996) A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334:1090-1094
20. Clemetson KJ (2001) Platelet receptors for adhesion and activation. Variability as a factor in susceptibility to cardiovascular diseases. Ital Heart J 2:816-818
21. Corral J, Gonzalez-Conejero R, Vicente V (2004) Genetic determinants of platelet function in thromboembolic diseases. J Biol Regul Homeost Agents 18:166-171
22. Meisel C, Lopez JA, Stangl K (2004) Role of platelet glycoprotein polymorphisms in cardiovascular diseases. Naunyn Schmiedebergs Arch Pharmacol 369:38-54
23. Böttiger C, Kastrati A, Koch W, Mehilli J, Seidl H, Schömig K, von Beckerath N, Schömig A (2000) HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 83:559-562
24. Hato T, Minamoto Y, Fukuyama T, Fujita S (1997) Polymorphism of HPA-1 through 6 on the platelet membrane glycoprotien receptors are not a genetic risk factor for myocardial infarction in the Japanese population. Am J Cardiol 80:1222-1224
25. Morita H, Kurihara H, Imai Y, Sugiyama T, Hamada C, Sakai E, Mori M, Nagai R (2001) Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and myocardial infarction in Japanese. An approach entailing melting curve analysis with specific fluorescent hybridization probes. Thromb Haemost 85:226-230
26. Kluter H (1996) Rapid typing for human platelet antigens systems-1,-2,-3 and-5 by PCR amplification sequence-specific primers. Vox Sang 71:121-123
27. Hurd CM, Cavanagh G, Schuh A, Ouwehand WH, Metcalfe P (2002) Genotyping for platelet-specific antigens: techniques for the detection of single nucleotide polymorphisms. Vox Sang 83:1-12
28. Janssens A, Pardo MC, Steyerberg EW, van Duijn CM (2004) Revisiting the clinical validity of multiplex genetic testing in complex diseases. Am J Hum Genet 74:585-588
29. Yang QH, Khoury MJ, Friedman JM, Little J, Flanders WD (2005) How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol 34:1129-1137
30. Jones DC, Bunce M, Fuggle SV, Young NT, Marshall SE (2003) Human platelet alloantigens (HPAs): PCR-SSP genotyping of a UK population for 15 HPA alleles. Eur J Immunogenet 30:415-419
31. Kekomaki S, Hamalainen L, Kauppinen Makelin R, Palomaki H, Kaste M, Kontula K (1999) Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke. J Cardiovasc Risk 6:13-17
32. Araújo F, Santos A, Araújo V, Henriques I, Monteiro F, Meireles E, Moreira I, David D, Maciel MJ, Cunha-Ribeiro LM (1999) Genetic risk factors in acute coronary disease. Haemostasis 29:212-218
33. Lagercrantz J, Bergman M, Lundman P, Tornvall P, Hjemdahl P, Hamsten A, Eriksson P (2003) No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction. Blood Coagul Fibrinolysis 14:749-753
34. Anderson JL, King GJ, Bair TL, Elmer SP, Muhlestein JB, Habashi J, Carlquist JF (1999) Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease. J Am Coll Cardiol 33:727-733
35. Zotz RB, Winkelmann BR, Müller C, Boehm BO, März W, Scharf RE (2005) Association of polymorphisms of platelet membrane integrins alpha IIb (beta) 3 (HPA-1b/Pl) and alpha2 (-beta) 1 (alpha807TT) with premature myocardial infarction. J Thromb Haemost 3:1522-1529
36. Lekakis J, Bisti S, Tsougos E, Papathanassiou A, Dagres N, Ikonomidis I, Soteriadou E, Tselepis AD, Goudevenos J, Kremastinos DT (2008) Platelet glycoprotein IIb HPA-3 polymorphism and acute coronary syndromes. Int J Cardiol 127:46-50
37. Park S, Park HY, Park C, Ko YG, Im EK, Jo I, Shin C, Lee JB, Shim WH, Cho SY, Jang Y (2004) Association of the gene polymorphisms of platelet glycoprotein Ia and IIb/IIIa with myocardial infarction and extent of coronary artery disease in the Korean population. Yonsei Med J 45:428-434
38. Li YH, Chen JH, Tsai WC, Chao TH, Guo HR, Tsai LM, Wu HL, Shi GY (2002) Synergistic effect of thrombomodulin promoter - 33G/A polymorphism and smoking on the onset of acute myocardial infarction. Thromb Haemost 87:86-91
39. Voetsch B, Damasceno BP, Camargo EC, Massaro A, Bacheschi LA, Scaff M, Annichino-Bizzacchi JM, Arruda VR (2000) Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 83:229-233
40. Charakida M, Tousoulis D, Stefanadis C, Toutouzas P (2003) The impact of platelet glycoprotein IIIa and Ia polymorphisms in cardiovascular thrombotic disease. Ital Heart J 4:17-22
41. Bojesen SE, Juul K, Schnohr P, Tybjaerg-Hansen A, Nordestgaard BG, Copenhagen City Heart Study (2003) Platelet glycoprotein IIb/IIIa Pl (A2)/Pl (A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study. J Am Coll Cardiol 42:661-667
42. Carlsson LE, Greinacher A, Spitzer C, Walther R, Kessler C (1997) Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke 28:1392-1395